Holen Sie sich die Stockscreener-App
76.75
0.81%
0.62
Handel nachbörslich:
75.21
-1.54
-2.01%
Schlusskurs vom Vortag:
$76.13
Offen:
$75.39
24-Stunden-Volumen:
1.22M
Relative Volume:
0.88
Marktkapitalisierung:
$13.29B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
9.4008
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
+3.13%
1M Leistung:
+11.28%
6M Leistung:
-7.42%
1J Leistung:
+5.48%
1-Tages-Spanne:
$74.71
$76.95
1-Wochen-Bereich:
$72.74
$76.95
52-Wochen-Spanne:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
76.75 | 13.18B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
439.80 | 159.03B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
146.25 | 40.49B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.93 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.10 | 30.65B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.98 | 30.44B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation - simplywall.st
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Solventum stock is recovering: What's going on? - MSN
3M Company stock (US88579Y1010): Q1 2026 earnings and Solventum spin-off reshape the industrial gian - AD HOC NEWS
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Shareholders Back Board, Pay and Auditor Choices - TipRanks
Solventum (NYSE: SOLV) shareholders approve directors, pay plan and PwC auditor - Stock Titan
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
What Are Wall Street Analysts' Target Price for Solventum Stock? - Barchart.com
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative? - simplywall.st
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) director Carlos Alban receives 3,300 restricted stock units - Stock Titan
Solventum Corp (SOLV) director receives 4,848 restricted stock units - Stock Titan
Solventum (SOLV) director Susan DeVore awarded 3,300 restricted stock units - Stock Titan
Solventum (SOLV) director receives 3,300 Restricted Stock Units as equity grant - Stock Titan
Director Glenn Eisenberg receives 3,300 Solventum (SOLV) restricted stock units - Stock Titan
Solventum (SOLV) director awarded 3,300 RSUs vesting in 2027 - Stock Titan
Solventum (SOLV) director Karen May receives grant of 3,300 RSUs - Stock Titan
Director at Solventum (NYSE: SOLV) receives 3,300 RSU equity grant - Stock Titan
Solventum Corp (SOLV) director receives grant of 3,300 RSUs vesting 2027 - Stock Titan
Solventum (SOLV) director awarded 3,300 restricted stock units vesting in 2027 - Stock Titan
Solventum (SOLV) director receives 3,300 RSU award vesting in 2027 - Stock Titan
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Solventum Corporation (SOLV) Stock Analysis: Exploring a 10.53% Upside in the Healthcare Sector - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the Dow veteran - AD HOC NEWS
Wedbush initiates coverage of Solventum (SOLV) with outperform recommendation - MSN
Solventum (NYSE: SOLV) CHRO settles RSUs with tax withholding, updates share stake - Stock Titan
Solventum (SOLV) CFO exercises RSUs and uses 4,404 shares for taxes - Stock Titan
Solventum (SOLV) supply chain chief exercises 3,960 RSUs, 1,678 shares withheld for tax - Stock Titan
Solventum (NYSE: SOLV) CAO vests RSUs; 728 shares withheld for taxes - Stock Titan
Solventum (SOLV) legal chief exercises 4,488 RSUs, with 1,952 shares for tax - Stock Titan
Solventum (SOLV) CEO exercises RSUs, uses 13,503 shares for tax withholding - Stock Titan
Solventum (SOLV) CIO exercises 4,422 RSUs, withholds 2,017 shares for taxes - Stock Titan
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the industrial conglomerate - AD HOC NEWS
3M (MMM) Spin-off Solventum Receives Outperform Rating from Wedb - GuruFocus
Solventum Seen Positioned for Meaningful Re-Rating Over Next 12 to 18 Months, Wedbush Says - marketscreener.com
Wedbush Initiates Solventum at Outperform With $94 Price Target - marketscreener.com
Wedbush initiates Solventum stock coverage at Outperform By Investing.com - Investing.com Australia
Wedbush initiates Solventum stock coverage at Outperform - Investing.com
Solventum’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Solventum’s Next Chapter May Hinge On Shedding Non-Core Units - Finimize
Solventum Foundation Expands Children’s Oral Health Access - Dentistry Today
Solventum Stock Tumbles as Tariff Fears Mount - TipRanks
Solventum Foundation and America's ToothFairy Launch National Effort to Expand Access to Preventive Dental Care - PR Newswire
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Why Solventum’s (NYSE:SOLV) Story Deserves Closer Attention? - Kalkine Media
Transcript : Solventum Corporation Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 10 - marketscreener.com
Solventum's (NYSE:SOLV) Solid Earnings May Rest On Weak Foundations - simplywall.st
7-Day Rally Sends Solventum Stock Up 13% - Trefis
Solventum Stock On Fire: Up 13% With 7-Day Winning Streak - Trefis
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.78%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):